People
Assertio Therapeutics, Inc. announced that Dr. David Wheadon has been appointed to the Company’s Board of Directors. Dr. Wheadon is a former senior executive of AstraZeneca plc.
Stevenage Bioscience Catalyst (SBC) has announced the appointment of two new Non-Executive Directors (NEDs) to its Board.
4BIO Capital, an international venture capital firm focused solely on the advanced therapies sector, announces that it has appointed Philippe Fauchet, OBE, as a Venture Partner based in Japan.
GENFIT announced Dr. Dean Hum’s appointment as President of GENFIT Corp. and Dr. Suneil Hosmane as Head of Global Diagnostics.
SCORR Marketing is excited to announce that Krystle Buntemeyer, president of SCORR Marketing, is the recipient of the 2019 Distinguished Young Alumni Award from the University of Nebraska at Kearney Alumni Association.
Appointment widens industry leadership perspective, translational and commercial expertise
Current Chief Executive Officer Albert Bourla will succeed Read as chairman on Jan. 1, 2020 and will continue to serve as CEO.
Ergomed plc,, a company focused on providing specialised services to the global pharmaceutical industry, announces that Peter George will step down from the Board with immediate effect to focus on his other business activities, in particular Benchmark Holdings plc where he was recently appointed Executive Chairman.
The adMare Academy is pleased to announce the latest Canadian life science leaders accepted into its Executive Institute -- a one-of-a-kind national executive development program custom designed to ensure that the Canadian life sciences sector has the management talent it needs to lead the world.
Biotech and pharma companies strengthen their leadership teams and boards of directors with this week’s appointments.
PRESS RELEASES